HIV-1 IMMUNOGENIC COMPOSITIONS
The present invention encompasses vaccine and/or immunogenic compositions against HIV and their methods of use for the prevention and/or treatment of HIV infection and/or AIDS. The vaccine and/or immunogenic compositions may contain an isolated HTV protein or fragment thereof, an adjuvant comprising...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | VOSS, GERALD, H MATHY, NATHALIE, L QUINNAN, GERALD, V BRODER, CHRISTOPHER, C |
| description | The present invention encompasses vaccine and/or immunogenic compositions against HIV and their methods of use for the prevention and/or treatment of HIV infection and/or AIDS. The vaccine and/or immunogenic compositions may contain an isolated HTV protein or fragment thereof, an adjuvant comprising a Toll like receptor (TLR) 4 ligand, in combination with a saponin.
La présente invention concerne un vaccin et/ou des compositions immunogènes anti-VIH, ainsi que leurs procédés d'utilisation pour prévenir et/ou traiter l'infection par le VIH et/ou le SIDA. Le vaccin et/ou les compositions immunogènes peuvent contenir une protéine HTV isolée ou un fragment de celle-ci, un adjuvant comprenant un ligand de récepteur de type Toll (Toll like receptor/ TLR) 4 en combinaison avec une saponine. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2007133573A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2007133573A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2007133573A13</originalsourceid><addsrcrecordid>eNrjZJDz8AzTNVTw9PUN9fN3d_XzdFZw9vcN8A_2DPH09wvmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBgbmhsbGpubGjobGxKkCAD1zIlo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HIV-1 IMMUNOGENIC COMPOSITIONS</title><source>esp@cenet</source><creator>VOSS, GERALD, H ; MATHY, NATHALIE, L ; QUINNAN, GERALD, V ; BRODER, CHRISTOPHER, C</creator><creatorcontrib>VOSS, GERALD, H ; MATHY, NATHALIE, L ; QUINNAN, GERALD, V ; BRODER, CHRISTOPHER, C</creatorcontrib><description>The present invention encompasses vaccine and/or immunogenic compositions against HIV and their methods of use for the prevention and/or treatment of HIV infection and/or AIDS. The vaccine and/or immunogenic compositions may contain an isolated HTV protein or fragment thereof, an adjuvant comprising a Toll like receptor (TLR) 4 ligand, in combination with a saponin.
La présente invention concerne un vaccin et/ou des compositions immunogènes anti-VIH, ainsi que leurs procédés d'utilisation pour prévenir et/ou traiter l'infection par le VIH et/ou le SIDA. Le vaccin et/ou les compositions immunogènes peuvent contenir une protéine HTV isolée ou un fragment de celle-ci, un adjuvant comprenant un ligand de récepteur de type Toll (Toll like receptor/ TLR) 4 en combinaison avec une saponine.</description><language>eng ; fre</language><subject>EMBANKMENTS ; EXCAVATIONS ; FIXED CONSTRUCTIONS ; FOUNDATIONS ; HYDRAULIC ENGINEERING ; SOIL SHIFTING ; UNDERGROUND OR UNDERWATER STRUCTURES</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071122&DB=EPODOC&CC=WO&NR=2007133573A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071122&DB=EPODOC&CC=WO&NR=2007133573A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VOSS, GERALD, H</creatorcontrib><creatorcontrib>MATHY, NATHALIE, L</creatorcontrib><creatorcontrib>QUINNAN, GERALD, V</creatorcontrib><creatorcontrib>BRODER, CHRISTOPHER, C</creatorcontrib><title>HIV-1 IMMUNOGENIC COMPOSITIONS</title><description>The present invention encompasses vaccine and/or immunogenic compositions against HIV and their methods of use for the prevention and/or treatment of HIV infection and/or AIDS. The vaccine and/or immunogenic compositions may contain an isolated HTV protein or fragment thereof, an adjuvant comprising a Toll like receptor (TLR) 4 ligand, in combination with a saponin.
La présente invention concerne un vaccin et/ou des compositions immunogènes anti-VIH, ainsi que leurs procédés d'utilisation pour prévenir et/ou traiter l'infection par le VIH et/ou le SIDA. Le vaccin et/ou les compositions immunogènes peuvent contenir une protéine HTV isolée ou un fragment de celle-ci, un adjuvant comprenant un ligand de récepteur de type Toll (Toll like receptor/ TLR) 4 en combinaison avec une saponine.</description><subject>EMBANKMENTS</subject><subject>EXCAVATIONS</subject><subject>FIXED CONSTRUCTIONS</subject><subject>FOUNDATIONS</subject><subject>HYDRAULIC ENGINEERING</subject><subject>SOIL SHIFTING</subject><subject>UNDERGROUND OR UNDERWATER STRUCTURES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDz8AzTNVTw9PUN9fN3d_XzdFZw9vcN8A_2DPH09wvmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBgbmhsbGpubGjobGxKkCAD1zIlo</recordid><startdate>20071122</startdate><enddate>20071122</enddate><creator>VOSS, GERALD, H</creator><creator>MATHY, NATHALIE, L</creator><creator>QUINNAN, GERALD, V</creator><creator>BRODER, CHRISTOPHER, C</creator><scope>EVB</scope></search><sort><creationdate>20071122</creationdate><title>HIV-1 IMMUNOGENIC COMPOSITIONS</title><author>VOSS, GERALD, H ; MATHY, NATHALIE, L ; QUINNAN, GERALD, V ; BRODER, CHRISTOPHER, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2007133573A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2007</creationdate><topic>EMBANKMENTS</topic><topic>EXCAVATIONS</topic><topic>FIXED CONSTRUCTIONS</topic><topic>FOUNDATIONS</topic><topic>HYDRAULIC ENGINEERING</topic><topic>SOIL SHIFTING</topic><topic>UNDERGROUND OR UNDERWATER STRUCTURES</topic><toplevel>online_resources</toplevel><creatorcontrib>VOSS, GERALD, H</creatorcontrib><creatorcontrib>MATHY, NATHALIE, L</creatorcontrib><creatorcontrib>QUINNAN, GERALD, V</creatorcontrib><creatorcontrib>BRODER, CHRISTOPHER, C</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VOSS, GERALD, H</au><au>MATHY, NATHALIE, L</au><au>QUINNAN, GERALD, V</au><au>BRODER, CHRISTOPHER, C</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HIV-1 IMMUNOGENIC COMPOSITIONS</title><date>2007-11-22</date><risdate>2007</risdate><abstract>The present invention encompasses vaccine and/or immunogenic compositions against HIV and their methods of use for the prevention and/or treatment of HIV infection and/or AIDS. The vaccine and/or immunogenic compositions may contain an isolated HTV protein or fragment thereof, an adjuvant comprising a Toll like receptor (TLR) 4 ligand, in combination with a saponin.
La présente invention concerne un vaccin et/ou des compositions immunogènes anti-VIH, ainsi que leurs procédés d'utilisation pour prévenir et/ou traiter l'infection par le VIH et/ou le SIDA. Le vaccin et/ou les compositions immunogènes peuvent contenir une protéine HTV isolée ou un fragment de celle-ci, un adjuvant comprenant un ligand de récepteur de type Toll (Toll like receptor/ TLR) 4 en combinaison avec une saponine.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2007133573A1 |
| source | esp@cenet |
| subjects | EMBANKMENTS EXCAVATIONS FIXED CONSTRUCTIONS FOUNDATIONS HYDRAULIC ENGINEERING SOIL SHIFTING UNDERGROUND OR UNDERWATER STRUCTURES |
| title | HIV-1 IMMUNOGENIC COMPOSITIONS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T03%3A51%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VOSS,%20GERALD,%20H&rft.date=2007-11-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2007133573A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |